Abfero Pharmaceuticals, Inc
1 clinical trials · Sponsor
◉ Watch Abfero Pharmaceuticals, Inc
| Record | Firm | Date |
|---|---|---|
| SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias (NCT03801889) | Abfero Pharmaceuticals, Inc | 2020-08-01 |
Track Abfero Pharmaceuticals, Inc automatically
Every clearance here is in the API, with alerts when new ones post.